How can I differentiate post‑traumatic stress disorder (PTSD) from major depressive disorder (MDD) and what are the appropriate treatment options for each?

Differentiating PTSD from Major Depressive Disorder

The key to distinguishing PTSD from MDD is identifying a clear traumatic event exposure followed by the four PTSD-specific symptom clusters: intrusive re-experiencing of the trauma, active avoidance behaviors, negative alterations in cognition/mood, and hyperarousal symptoms—features that are absent in MDD.

Clinical Differentiation

Essential Diagnostic Features

PTSD requires:

• Documented exposure to actual or threatened death, serious injury, or sexual violence (either directly experienced, witnessed, or learned about in close others) 11
• Symptoms persisting >1 month causing clinically significant distress or functional impairment 2
• Four distinct symptom clusters that differentiate it from depression 3:
  • Intrusive re-experiencing: flashbacks, nightmares, intrusive memories of the specific trauma
  • Active avoidance: deliberate efforts to avoid trauma-related thoughts, feelings, people, places, or activities
  • Negative cognitions/mood: persistent negative beliefs about self/world, distorted blame, persistent negative emotional state
  • Hyperarousal: exaggerated startle response, hypervigilance, irritability, reckless behavior

MDD lacks:

• The requirement for traumatic event exposure
• Trauma-specific intrusive re-experiencing symptoms
• Active trauma-related avoidance behaviors
• Hyperarousal symptoms tied to trauma reminders

Distinguishing Clinical Features

Experienced clinicians can readily differentiate these conditions 4. While both disorders share overlapping symptoms (depressed mood, anhedonia, concentration difficulties, sleep disturbance), the presence of trauma-specific intrusions and avoidance behaviors is pathognomonic for PTSD.

Critical differentiating symptoms:

• Feeling distant/cut off and difficulty concentrating are most central in PTSD networks post-trauma 5
• Sleep problems serve as bridge symptoms between disorders but manifest differently: PTSD involves trauma-related nightmares; MDD involves early morning awakening or hypersomnia 5
• Emotional numbing in PTSD is trauma-specific; anhedonia in MDD is generalized 6

Common Pitfall: High Comorbidity

PTSD and MDD frequently co-occur (up to 87% of PTSD cases involve interpersonal trauma with high MDD comorbidity) 36. When both are present:

• Pre-existing psychiatric history doubles the risk of developing PTSD, MDD, or anxiety post-trauma (16-28% vs 5-13% at 1 year) 7
• Both diagnoses should be made when full criteria are met for each
• The traumatic event temporally precedes PTSD symptom onset, while MDD may predate or follow trauma exposure

Treatment Approaches

PTSD Treatment Algorithm

First-line treatment: Trauma-focused psychotherapy over pharmacotherapy 111

Strongly recommended psychotherapies (in order of evidence strength):

1. Prolonged Exposure (PE)
2. Cognitive Processing Therapy (CPT)
3. Eye Movement Desensitization and Reprocessing (EMDR)

These manualized therapies have the highest quality evidence for reducing PTSD symptoms and improving quality of life 12.

Pharmacotherapy (when psychotherapy unavailable, refused, or as adjunct):

• First-line medications: Paroxetine, sertraline, or venlafaxine 112
• Strongly recommend AGAINST: Benzodiazepines, cannabis, or cannabis-derived products 11

Delivery method:

• Secure video teleconferencing is recommended when validated for the specific therapy or when in-person options are unavailable 11

MDD Treatment Algorithm

First-line options (no hierarchy among these):

• Psychotherapies: CBT, behavioral activation, interpersonal psychotherapy, acceptance and commitment therapy, problem-solving therapy, mindfulness-based cognitive therapy, or short-term psychodynamic psychotherapy 8
• Pharmacotherapy: SSRIs or SNRIs
• Adjunctive/alternative: Clinician-guided computer/internet-based CBT 8
• For mild-moderate MDD: Bright light therapy (regardless of seasonal pattern) 8

For treatment-resistant MDD:

• Repetitive transcranial magnetic stimulation (rTMS) after failure of ≥2 adequate pharmacologic trials 8

Comorbid PTSD and MDD

When both disorders are present, treat PTSD first 6. Evidence shows:

• Sequential treatment with CPT for PTSD followed by behavioral activation for residual MDD symptoms produces superior outcomes compared to treating MDD first or PTSD alone
• At 6-month follow-up, 49% achieved remission of both disorders with CPT-then-BA versus 18% with CPT alone 6
• Targeting PTSD first addresses the trauma-specific symptoms while often improving comorbid depressive symptoms

Key Treatment Principles

Avoid these common errors:

• Do not use benzodiazepines for PTSD—they are contraindicated and may worsen outcomes 11
• Do not delay trauma-focused psychotherapy in favor of "stabilization" with medications alone
• Do not treat comorbid depression first when PTSD is present—address the trauma-focused disorder initially 6

Optimize outcomes by:

• Prioritizing evidence-based psychotherapies as first-line for PTSD
• Using shared decision-making to select specific therapy modality based on patient preference and provider training
• Considering telemedicine delivery when access is limited
• Monitoring for treatment response and adjusting approach if inadequate improvement after adequate trial